Cipla to sell Eli Lilly’s Basaglar insulin in India

Indian pharmaceutical giant Cipla Ltd said it would sell Eli Lilly and Co’s insulin glargine in India. Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. Unlike regular insulin shots — which have to be taken multiple times a day — basal insulin releases […]

Lopinavir syrup for children with HIV now available across India – Govt

Minister of health and family welfare Anupriya Patel said Lopinavir syrup, the life-saving drug given to infants and toddlers with HIV has been restocked by the National Aids Control Organization. “NACO has done an emergency procurement from a registered manufacturer — McNeil and Argus. The drug has already been supplied and is available throughout the […]

Cipla redraws Iran plans with new agreement, to invest Rs 121 cr

Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran. An earlier agreement executed by the Company with the Iranian firm has been terminated. The total investment will be euro 16.875 million, which comes […]

FDA observations ‘primarily procedural’ –

USFDA issued four observations about Cipla’s manufacturing facilities in Goa after conducting an audit, the company said. Cipla has three facilities in Goa. “The observations were primarily procedural in nature and the company has already responded to these observations,” said the pharma company. Further details were not given. The company said it will continue to operate their […]